Status:
COMPLETED
A Safety and Tolerability Study of ABT-126 in Elderly
Lead Sponsor:
Abbott
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
65+ years
Phase:
PHASE1
Brief Summary
The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.
Eligibility Criteria
Inclusion
- Healthy male or female subjects 65 years or greater.
- Has a MMSE score of 27 or higher.
Exclusion
- History of dementia including by not limited to Alzheimer's disease, Parkinson's disease and mult-infarct dementia.
- History of any significant neurological disease.
- Has an estimated creatinine clearance \< 30 mL/min
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00867399
Start Date
March 1 2009
Last Update
November 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 17283
Orlando, Florida, United States, 32809